What is the consensus on giving Pemivibart for Pre-Exposure COVID prophylaxis in immunocompromised patients?

The SARS-COV2 virus that caused COVID-19 infection in the early pandemic caused significant morbidity and mortality to immunocompromised patients including those with blood cancers. Therapies such as remdesivir, paxlovid, antibody neutralizing therapeutics Evusheld antibody for prophylaxis, and the vaccines toward SARS-COV2 were transforming for preventing and treating this disease. As the pandemic evolved to the place we are at today, the life-threatening impact of SARS-COV2 infection when trea...